Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Finerenone Tablets versus Firialta in healthy Thai adults under fasting conditions
TCTR20260909006Phase 1Not yet recruiting
- Sponsor
- Dr. Sasitorn Kittivoravitkul
- Start
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of finerenone (2 arms), sponsored by Dr. Sasitorn Kittivoravitkul. Primary endpoints: Maximum plasma concentration, Area under the plasma concentration-time curve to last observed concentration and 1 more. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
finerenone
Beyond the preview
Go deeper on TCTR20260909006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260909006.